WuXi Vaccines, a subsidiary of WuXi Biologics, is a leading force in human vaccine discovery, development, and manufacturing. WuXi Vaccines purpose is to revolutionize the global vaccine industry by introducing world-class integrated platforms and a cutting-edge CDMO (Contract Development and Manufacturing Organization) business model, synonymous with WuXi Biologics’ stellar reputation.
The project is an integrated vaccine manufacturing facility which encompasses drug substance manufacturing (DS), drug product manufacturing (DP), Manufacture Science and Technology Labs (MS&T), and Quality Control labs (QC). Its primary objective will be to produce our partner’s vaccine products for the global market, solidifying WuXi Vaccines’ standing as a pivotal player in the vaccine industry.
This state-of-the-art facility will have a strong commitment to scientific excellence and global health, and is poised to make a profound impact on the future of vaccine development and manufacturing.
